Exploring Old Drugs for the Treatment of Hematological Malignancies

Author(s): F. Gan, B. Cao, D. Wu, Z. Chen, T. Hou, X. Mao

Journal Name: Current Medicinal Chemistry

Volume 18 , Issue 10 , 2011

Become EABM
Become Reviewer


Drug discovery is costly and time-consuming, but it will become easier and simpler if a drug could be developed from an old one with well-documented investigations associated with pharmacology, pharmacokinetics, toxicology and clinical safety. In terms of hematological malignancies, several successful drugs have been discovered and developed from old ones such as arsenic trioxide for acute promyelocytic leukemia and thalidomide for multiple myeloma. In this review, we discussed the latest advancement in exploring old drugs for the treatment of hematological malignancies.

Keywords: Drug repositioning, drug discovery, old drug, hematological malignancy, drug, arsenic trioxide, pharmacological, therapeutic, dysfunction, methotrexate, rheumatoid arthritis, hematological malignancies

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [1509 - 1514]
Pages: 6
DOI: 10.2174/092986711795328427
Price: $65

Article Metrics

PDF: 5